Severe nausea, vomiting, and dizziness are less commonly reported with sublingual formulations, though they can still occur, especially at higher doses or when escalating too quickly
Clin Pharmacol Ther 2017, 102(2): 290-296
Lira (GLP-1R) can reduce the occurrence of hepatic steatosis in vivo and in vitro by enhancing autophagy and lipid degradation through the GLP-1R-transcription factor EB (TFEB)-mediated autophagy lysosomal pathway [37]
Delayed gastric emptying: As a class effect, incretin agents slow gastric emptying, which may affect the absorption of orally administered medicines
With key GLP-1 drug patents expected to expire around March 2026, Indian pharmaceutical companies are preparing to launch lower-cost alternatives in one of the fastest-growing therapeutic markets
That is the entire reason this comparison exists